MedTrace Logo

Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding

NCT07502729 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1066

Last updated 2026-03-31

No results posted yet for this study

Summary

This study aims to evaluate the impact of high-risk factors-such as elevated portal venous pressure, concurrent large extra-luminal vessels, portal vein thrombosis, and prominent portosystemic shunts-on the efficacy of endoscopic therapy. By comparing with interventional treatment, the goal is to optimize the clinical management protocol for esophageal and gastric varices, enhance the therapeutic outcomes of portal hypertension-related esophageal and gastric varices, and improve patient prognosis.

Conditions

  • Portal Hypertension
  • Gastroesophageal Varices Hemorrhage
  • Gastric Varices
  • Esophageal Varices

Sponsors & Collaborators

  • RenJi Hospital

    collaborator OTHER

  • Shandong Provincial Hospital

    collaborator OTHER_GOV

  • Qilu Hospital of Shandong University

    collaborator OTHER

  • Third Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER

  • Shanghai East Hospital

    collaborator OTHER

  • Shanghai Changzheng Hospital

    collaborator OTHER

  • Second Military Medical University

    collaborator OTHER

  • The General Hospital of Northern Theater Command

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-17
Primary Completion
2026-12-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07502729 on ClinicalTrials.gov